DoD's Defense Health Agency Awards $2.4M for Biotech R&D to Kapili Services, LLC
Contract Overview
Contract Amount: $2,407,008 ($2.4M)
Contractor: Kapili Services, LLC
Awarding Agency: Department of Defense
Start Date: 2025-01-09
End Date: 2027-01-08
Contract Duration: 729 days
Daily Burn Rate: $3.3K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 2
Pricing Type: FIRM FIXED PRICE
Sector: R&D
Official Description: RESEARCH SUPPORT SERVICES
Place of Performance
Location: SAN ANTONIO, BEXAR County, TEXAS, 78234
State: Texas Government Spending
Plain-Language Summary
Department of Defense obligated $2.4 million to KAPILI SERVICES, LLC for work described as: RESEARCH SUPPORT SERVICES Key points: 1. Contract value of $2.4M for specialized biotech R&D. 2. Competition type is 'Full and Open', indicating broad market access. 3. Risk appears moderate given the specialized nature of R&D services. 4. Sector focus is R&D in Biotechnology, a critical area for defense health.
Value Assessment
Rating: good
The contract value of $2.4M for a 2-year period seems reasonable for specialized R&D services. Benchmarking against similar contracts for biotechnology research support would provide a more precise assessment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The 'Full and Open Competition' method suggests a robust price discovery process. This approach allows multiple qualified vendors to bid, potentially driving down costs and ensuring fair market pricing.
Taxpayer Impact: The competitive nature of this award is positive for taxpayers, as it likely resulted in a more efficient use of funds compared to a sole-source procurement.
Public Impact
Supports critical research and development in biotechnology for defense health. Potential for advancements in medical treatments and capabilities. Contract awarded through a competitive process, benefiting taxpayer value.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for scope creep in R&D projects.
- Dependence on specific expertise of Kapili Services, LLC.
- Uncertainty in R&D outcomes and timelines.
Positive Signals
- Competitive award process.
- Focus on a high-priority R&D area.
- Clear contract duration and pricing structure.
Sector Analysis
This contract falls within the Research and Development in Biotechnology sector, a field crucial for advancing military medicine and healthcare. Spending in this area is often characterized by high innovation potential but also inherent risks and long development cycles.
Small Business Impact
The contract was awarded via full and open competition, which does not inherently exclude small businesses. However, the data does not specify if small businesses participated or were subcontracted.
Oversight & Accountability
The Defense Health Agency is responsible for overseeing this contract. Standard oversight mechanisms for R&D contracts, including progress reports and milestone reviews, should be in place to ensure accountability.
Related Government Programs
- Research and Development in Biotechnology (except Nanobiotechnology)
- Department of Defense Contracting
- Defense Health Agency Programs
Risk Flags
- Potential for R&D project delays.
- Reliance on specialized technical expertise.
- Uncertainty of research outcomes.
- Need for robust performance monitoring.
Tags
research-and-development-in-biotechnolog, department-of-defense, tx, delivery-order, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Defense awarded $2.4 million to KAPILI SERVICES, LLC. RESEARCH SUPPORT SERVICES
Who is the contractor on this award?
The obligated recipient is KAPILI SERVICES, LLC.
Which agency awarded this contract?
Awarding agency: Department of Defense (Defense Health Agency).
What is the total obligated amount?
The obligated amount is $2.4 million.
What is the period of performance?
Start: 2025-01-09. End: 2027-01-08.
What is the specific research objective and expected outcome of this contract?
The specific research objective and expected outcome are not detailed in the provided data. Further information from the contract's statement of work or related documentation would be necessary to understand the precise goals and anticipated deliverables for this biotechnology R&D effort.
What are the key performance indicators (KPIs) for this contract?
Key performance indicators are not explicitly stated in the provided data. For R&D contracts, KPIs typically focus on research progress, milestone achievement, scientific validity, and timely delivery of reports or prototypes. The contracting officer would establish these based on the project's specific needs.
How does the pricing structure align with industry standards for similar R&D projects?
The contract uses a Firm Fixed Price (FFP) structure, which is common. However, without specific details on the scope of work and deliverables, it's difficult to benchmark against industry standards for similar R&D projects. A detailed cost analysis would be needed to assess pricing alignment.
Industry Classification
NAICS: Professional, Scientific, and Technical Services › Scientific Research and Development Services › Research and Development in Biotechnology (except Nanobiotechnology)
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Solicitation ID: HT942525R0010
Offers Received: 2
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 2300 DISCOVERY DR STE 600, ORLANDO, FL, 32826
Business Categories: 8(a) Program Participant, Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Minority Owned Business, Native American Owned Business, Native Hawaiian Organization Owned Firm, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $16,124,978
Exercised Options: $5,410,477
Current Obligation: $2,407,008
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: HT001122D0025
IDV Type: IDC
Timeline
Start Date: 2025-01-09
Current End Date: 2027-01-08
Potential End Date: 2030-01-08 00:00:00
Last Modified: 2026-01-07
More Contracts from Kapili Services, LLC
- Defense Threat Reduction Information Analysis Center Operations — $32.7M (Department of Defense)
- THE Contractor Will Provide End-User Sustainment Support Training to Military Facilities and Defense Health Agency End-Users on the Legacy Electronic Health Record, Health Solutions, and Legacy Applications — $28.2M (Department of Defense)
- Virtual Health PMO — $27.3M (Department of Defense)
- Vision Center of Excellence Education and Clinical Research Program Support — $6.9M (Department of Defense)
Other Department of Defense Contracts
- Federal Contract — $51.3B (Humana Government Business Inc)
- Lrip LOT 12 Advance Acquisition Contract — $35.1B (Lockheed Martin Corporation)
- SSN 802 and 803 Long Lead Time Material — $34.7B (Electric Boat Corporation)
- 200204!008532!1700!AF600 !naval AIR Systems Command !N0001902C3002 !A!N! !N! !20011026!20120430!008016958!008016958!834951691!n!lockheed Martin Corporation !lockheed Blvd !fort Worth !tx!76108!27000!439!48!fort Worth !tarrant !texas !+000026000000!n!n!018981928201!ac15!rdte/Aircraft-Eng/Manuf Develop !a1a!airframes and Spares !2ama!jast/Jsf !336411!E! !3! ! ! ! ! !99990909!B! ! !A! !a!n!r!2!002!n!1a!a!n!z! ! !N!C!N! ! ! !a!a!a!a!000!a!c!n! ! ! !Y! !N00019!0001! — $34.2B (Lockheed Martin Corporation)
- KC-X Modernization Program — $32.0B (THE Boeing Company)